NIAID
The new, highly mutated SARS-CoV-2 strain circulating in the United Kingdom is likely already sowing COVID-19 around the world, scientists say, fueling worries about recent surges that have swamped hospitals and whether it can thwart currently authorized vaccines.
The fact that the variant has developed 23 mutations in a matter of months is also reason for concern, top US experts say.
The variant, called B.1.1.7, has caused upwards of 50% of COVID-19 cases from Oct 5 and Dec 13 in the UK, mostly in people younger than 60 years, according to a Dec 21 World Health Organization report. An observed increase in the virus reproduction number (R
Brigham and Womenâs doctor calls for more self-administered COVID-19 tests to stop the spread
By Travis Andersen Globe Staff,Updated December 22, 2020, 10:53 a.m.
Email to a Friend
US regulators recently approved emergency use of the first rapid coronavirus test that consumers can buy without a prescription to test themselves entirely at home, developed by Australian manufacturer Ellume.Associated Press
A Brigham and Womenâs Hospital researcher has coauthored a new paper in the journal Science that calls for more widespread COVID-19 testing in an effort to combat the spread of the virus.
âThe way that this screening works is to have enough people test themselves frequently â say, twice per week â ideally using rapid tests,â said Dr. Michael Mina, the paperâs coauthor, who also serves as associate medical director in clinical microbiology at the Brigham, in a statement released by the hospital. âBy empowering people with the knowledge of th
Date Time
Three FAU researchers receive ERC Consolidator Grants
Another success for researchers at FAU: FAU researchers receive three ERC Consolidator Grants. Prof. Dr. Gerhard Krönke and Prof. Dr. Aline Bozec, both from the Chair of Internal Medicine III, and Henry Dube, Chair of Organic Chemistry I have each received one of the coveted ERC Consolidator Grants from the European Research Council (ERC).
Investigating the onset of rheumatoid arthritis
Prof. Dr. Gerhard Krönke, Chair of Internal Medicine at FAU (Image: FAU/Erich Malter)
Principal investigator Prof. Dr. Gerhard Krönke would like to use his grant to research the early stages of rheumatoid arthritis and hopefully discover new means of treatment. Rheumatoid arthritis is one of the most common inflammatory autoimmune diseases in the world. It is caused by a malfunction in the body’s own immune system which leads to chronic, painful joint inflammation and joint destruction. Although there is no cure for the disease